70 related articles for article (PubMed ID: 19284373)
21. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Tkach M; Coria L; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Beguelin W; Frahm I; Charreau EH; Cassataro J; Elizalde PV; Schillaci R
J Immunol; 2012 Aug; 189(3):1162-72. PubMed ID: 22753933
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
Wang S; Huang X; Lee CK; Liu B
Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
[TBL] [Abstract][Full Text] [Related]
24. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
Ling X; Arlinghaus RB
Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
[TBL] [Abstract][Full Text] [Related]
26. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
[TBL] [Abstract][Full Text] [Related]
28. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.
Lee JH; Schütte D; Wulf G; Füzesi L; Radzun HJ; Schweyer S; Engel W; Nayernia K
Hum Mol Genet; 2006 Jan; 15(2):201-11. PubMed ID: 16377660
[TBL] [Abstract][Full Text] [Related]
29. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
[TBL] [Abstract][Full Text] [Related]
30. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
32. Furanodienone induces cell cycle arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast cancer cells.
Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1315-23. PubMed ID: 21461888
[TBL] [Abstract][Full Text] [Related]
33. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
34. Effect and mechanism of YB-1 knockdown on glioma cell growth, migration, and apoptosis.
Gong H; Gao S; Yu C; Li M; Liu P; Zhang G; Song J; Zheng J
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):168-179. PubMed ID: 32047913
[TBL] [Abstract][Full Text] [Related]
35. YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms.
Johnson TG; Schelch K; Lai K; Marzec KA; Kennerson M; Grusch M; Reid G; Burgess A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823952
[TBL] [Abstract][Full Text] [Related]
36. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
Lin Z; Lu Y; Meng Q; Wang C; Li X; Yang Y; Xin X; Zheng Q; Xu J; Gui X; Li T; Pu H; Xiong W; Li J; Jia S; Lu D
Mol Ther Nucleic Acids; 2018 Jun; 11():494-507. PubMed ID: 29858084
[TBL] [Abstract][Full Text] [Related]
37.
Fan J; Zhang Z; Chen H; Chen D; Yuan W; Li J; Zeng Y; Zhou S; Zhang S; Zhang G; Xiong J; Zhou L; Xu J; Liu W; Xu Y
Genes Dis; 2024 Jan; 11(1):430-448. PubMed ID: 37588209
[TBL] [Abstract][Full Text] [Related]
38. YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.
Wu J; Stratford AL; Astanehe A; Dunn SE
Transl Oncogenomics; 2007; 2():49-65. PubMed ID: 23641145
[TBL] [Abstract][Full Text] [Related]
39. STAT3 pathway as a molecular target for resveratrol in breast cancer treatment.
Kohandel Z; Farkhondeh T; Aschner M; Pourbagher-Shahri AM; Samarghandian S
Cancer Cell Int; 2021 Sep; 21(1):468. PubMed ID: 34488773
[TBL] [Abstract][Full Text] [Related]
40. Expression of Concern: STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
Salguero-Aranda C; Sancho-Mensat D; Canals-Lorente B; Sultan S; Reginald A; Chapman L
PLoS One; 2021; 16(1):e0246415. PubMed ID: 33508033
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
